Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
2003 1
2006 1
2007 1
2008 1
2010 1
2011 1
2012 1
2013 4
2014 1
2015 1
2016 2
2017 4
2018 6
2019 6
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis.
Damman JL, Rodriguez EA, Ali AH, Buness CW, Cox KL, Carey EJ, Lindor KD. Damman JL, et al. Aliment Pharmacol Ther. 2018 Apr;47(7):886-895. doi: 10.1111/apt.14540. Epub 2018 Feb 7. Aliment Pharmacol Ther. 2018. PMID: 29411404 Free article. Review.
In this review, we summarise the current evidence on the use of vancomycin in PSC and comment on future research areas of interest. ...Further research is needed to establish if vancomycin is a PSC treatment....
In this review, we summarise the current evidence on the use of vancomycin in PSC and comment on future research areas of interest. . …
Pharmacologic management of primary sclerosing cholangitis: what's in the pipeline?
Suri J, Patwardhan V, Bonder A. Suri J, et al. Expert Rev Gastroenterol Hepatol. 2019 Aug;13(8):723-729. doi: 10.1080/17474124.2019.1636647. Epub 2019 Jul 1. Expert Rev Gastroenterol Hepatol. 2019. PMID: 31257956 Review.
Introduction: Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease characterized by biliary inflammation, fibrosis, and stricturing. ...Some are already used for other treatment indications, including antibiotics such as oral vancomycin
Introduction: Primary sclerosing cholangitis (PSC) is a rare cholestatic liver disease characterized by biliary inflamm …
Effects of Antibiotic Therapy in Primary Sclerosing Cholangitis with and without Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Shah A, Crawford D, Burger D, Martin N, Walker M, Talley NJ, Tallis C, Jones M, Stuart K, Keely S, Lewindon P, Macdonald GA, Morrison M, Holtmann GJ. Shah A, et al. Semin Liver Dis. 2019 Nov;39(4):432-441. doi: 10.1055/s-0039-1688501. Epub 2019 Jul 17. Semin Liver Dis. 2019. PMID: 31315136
The authors conducted a systematic review and meta-analysis to assess the effect of antibiotic therapy in primary sclerosing cholangitis (PSC). ...Antibiotics, particularly vancomycin, may have a positive effect on PSC either via direct effects on the …
The authors conducted a systematic review and meta-analysis to assess the effect of antibiotic therapy in primary sclerosing
Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis.
de Chambrun GP, Nachury M, Funakoshi N, Gerard R, Bismuth M, Valats JC, Panaro F, Navarro F, Desreumaux P, Pariente B, Blanc P. de Chambrun GP, et al. Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1247-1252. doi: 10.1097/MEG.0000000000001223. Eur J Gastroenterol Hepatol. 2018. PMID: 30052539
The treatment of UC is challenging, especially when it is associated with primary sclerosing cholangitis (PSC), a chronic inflammatory disease of the bile ducts that affects around 5% of patients with UC, and leads to an increased risk of cholangiocarcinoma a …
The treatment of UC is challenging, especially when it is associated with primary sclerosing cholangitis (PSC), a chron …
A Triple Blinded, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of Oral Vancomycin in Primary Sclerosing Cholangitis: a Pilot Study.
Rahimpour S, Nasiri-Toosi M, Khalili H, Ebrahimi-Daryani N, Nouri-Taromlou MK, Azizi Z. Rahimpour S, et al. J Gastrointestin Liver Dis. 2016 Dec;25(4):457-464. doi: 10.15403/jgld.2014.1121.254.rah. J Gastrointestin Liver Dis. 2016. PMID: 27981301 Free article. Clinical Trial.
BACKGROUND AND AIM: Recent studies have suggested the therapeutic effect of antimicrobial agents on primary sclerosing cholangitis (PSC). ...Primary endpoints were accomplished in the vancomycin group showing a significant decline in the mean le …
BACKGROUND AND AIM: Recent studies have suggested the therapeutic effect of antimicrobial agents on primary sclerosing chol
Treatment of primary sclerosing cholangitis in children.
Laborda TJ, Jensen MK, Kavan M, Deneau M. Laborda TJ, et al. World J Hepatol. 2019 Jan 27;11(1):19-36. doi: 10.4254/wjh.v11.i1.19. World J Hepatol. 2019. PMID: 30705716 Free PMC article. Review.
Primary sclerosing cholangitis (PSC) is a rare disease of stricturing and destruction of the biliary tree with a complex genetic and environmental etiology. ...Ursodeoxycholic acid and oral vancomycin therapy used widely in children as medical therapy,
Primary sclerosing cholangitis (PSC) is a rare disease of stricturing and destruction of the biliary tree with a comple
Oral vancomycin induces clinical and mucosal remission of colitis in children with primary sclerosing cholangitis-ulcerative colitis.
Tan LZ, Reilly CR, Steward-Harrison LC, Balouch F, Muir R, Lewindon PJ. Tan LZ, et al. Gut. 2019 Aug;68(8):1533-1535. doi: 10.1136/gutjnl-2018-316599. Epub 2018 Aug 21. Gut. 2019. PMID: 30131321 No abstract available.
Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study.
Tabibian JH, Weeding E, Jorgensen RA, Petz JL, Keach JC, Talwalkar JA, Lindor KD. Tabibian JH, et al. Aliment Pharmacol Ther. 2013 Mar;37(6):604-12. doi: 10.1111/apt.12232. Epub 2013 Feb 5. Aliment Pharmacol Ther. 2013. PMID: 23384404 Free article. Clinical Trial.
BACKGROUND: Emerging data suggest that oral antibiotics may have therapeutic effects in primary sclerosing cholangitis (PSC), but published studies are limited. ...Larger, longer-term studies are needed to further examine the safety and efficacy of antibiotic …
BACKGROUND: Emerging data suggest that oral antibiotics may have therapeutic effects in primary sclerosing cholangitis
A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis.
Vaughn BP, Kaiser T, Staley C, Hamilton MJ, Reich J, Graiziger C, Singroy S, Kabage AJ, Sadowsky MJ, Khoruts A. Vaughn BP, et al. Clin Exp Gastroenterol. 2019 Jan 10;12:9-19. doi: 10.2147/CEG.S186097. eCollection 2019. Clin Exp Gastroenterol. 2019. PMID: 30666146 Free PMC article.
Primary sclerosing cholangitis (PSC) is associated with IBD and markedly increases the risk of colon cancer. We hypothesized that secondary bile acids, which are products of microbial metabolism, are increased in PSC patients. ...For subjects with IBD/PSC, or
Primary sclerosing cholangitis (PSC) is associated with IBD and markedly increases the risk of colon cancer. We hypothe
33 results
Jump to page
Feedback